Dallas-based Valesco Industries has completed the sale of its interests in Drug Free Sport International to CPC LLC, a Kansas City, Missouri-based investment company.
Financial details of the transaction were not disclosed. Valesco said it made a control investment in DFSI in January 2017, and DFSI subsequently merged with Stockholm, Sweden-based IDTM in September 2018.
Kansas City-based DFSI is an international third-party administrator of unbiased and customized drug prevention/education and drug-testing programs for professional, collegiate, and amateur sports organizations, as well as a third-party service provider for clinical and mobile health services.
“Valesco Industries has been instrumental in helping Drug Free Sport refine critical business processes, expand its value proposition and enable growth with supporting resources to enhance our position in the market,” DSFI CEO Chris Guinty said in a statement. “Valesco felt like a partner and was interested in the success and legacy of the business rather than returns.”
Valesco said that during the period of its investment, the company accomplished major initiatives in the areas of people, processes, and systems integrations while growing sales and EBITDA to company record levels.
According to its website, CPC seeks to invest $60 million to $120+ million per company into control investments.
Boxwood Partners was the exclusive adviser to Drug Free Sport and Valesco Industries.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.